Rapid attenuation of anti-SARS-CoV-2 antibody in patients with musculoskeletal diseases who reinitiated intensive immunosuppressive therapies after COVID-19.
暂无分享，去创建一个
S. Higa | A. Ogata | S. Kawada | K. Kawamoto | A. Kumanogoh | Y. Kato | T. Morita | M. Okamoto | N. Ishikawa | Kazuki Matsukawa | Y. Yamaguchi | H. Shimagami | N. Fujii | Yutaka Ishida